Leslie Lobel

Leslie Lobel (; deceased 2018) was an American-born Israeli virologist and physician at Ben-Gurion University in Israel, where he was a leading researcher attempting to develop a vaccine and cure for infectious diseases, primarily Ebola. He was Chair of their Department of Virology and Developmental Genetics, and Vice Chair of the Department of Microbiology, Immunology and Genetics.

Partnering with both the U.S. military and the Uganda Virus Research Institute, his focus since moving to Israel in 2002, had been on isolating human monoclonal antibodies as a drug which could be manufactured to give people immunity against a number of infectious diseases. With his co-investigator, Dr. Victoria Yavelsky, he had hoped to create a "passive" vaccine which would offer protection immediately after being given. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Leslie Lobel', query time: 0.06s Refine Results
  1. 1
    Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI

    Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI by Olga Radinsky, Avishay Edri, Michael Brusilovsky, Shlomit Fedida-Metula, Ariel Sobarzo, Orly Gershoni-Yahalom, Julius Lutwama, John Dye, Leslie Lobel, Angel Porgador

    Published 2017-07-01
    Get full text
    Article
  2. 2
    N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion

    N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion by Muhammed Iraqi, Avishay Edri, Yariv Greenshpan, Kiran Kundu, Kiran Kundu, Priyanka Bolel, Avishag Cahana, Aner Ottolenghi, Roi Gazit, Leslie Lobel, Alex Braiman, Angel Porgador, Angel Porgador

    Published 2020-03-01
    Get full text
    Article
  3. 3
    Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivorsResearch in context

    Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivorsResearch in context by Ariel Sobarzo, Spencer W. Stonier, Olga Radinsky, Sigal Gelkop, Ana I. Kuehne, Avishay Edri, Andrew S. Herbert, Shlomit Fedida-Metula, Julius Julian Lutwama, Victoria Yavelsky, Claytus Davis, Angel Porgador, John M. Dye, Leslie Lobel

    Published 2019-08-01
    Get full text
    Article
  4. 4
    Neutralizing Antibodies against Crimean–Congo Hemorrhagic Fever Virus Derived from a Human Survivor

    Neutralizing Antibodies against Crimean–Congo Hemorrhagic Fever Virus Derived from a Human Survivor by J. Maximilian Fels, Daniel Maurer, Ana I. Kuehne, Dafna M. Abelson, Noel T. Pauli, Andrew S. Herbert, John M. Dye, Robert W. Cross, Thomas W. Geisbert, Leslie Lobel, Zachary A. Bornholdt, Laura M. Walker, Kartik Chandran

    Published 2020-07-01
    Get full text
    Article
  5. 5
    Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors

    Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors by Ariel Sobarzo, Spencer W. Stonier, Andrew S. Herbert, David E. Ochayon, Ana I. Kuehne, Yael Eskira, Shlomit Fedida-Metula, Neta Tali, Eli C. Lewis, Moses Egesa, Stephen Cose, Julius Julian Lutwama, Victoria Yavelsky, John M. Dye, Leslie Lobel

    Published 2016-05-01
    Get full text
    Article
  6. 6
    Immune Memory to Sudan Virus: Comparison between Two Separate Disease Outbreaks

    Immune Memory to Sudan Virus: Comparison between Two Separate Disease Outbreaks by Ariel Sobarzo, Yael Eskira, Andrew S. Herbert, Ana I. Kuehne, Spencer W. Stonier, David E. Ochayon, Shlomit Fedida-Metula, Steven Balinandi, Yaara Kislev, Neta Tali, Eli C. Lewis, Julius Julian Lutwama, John M. Dye, Victoria Yavelsky, Leslie Lobel

    Published 2015-01-01
    Get full text
    Article
  7. 7
    Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38

    Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38 by Olivia S. Shin, Stephanie R. Monticelli, Christy K. Hjorth, Vladlena Hornet, Michael Doyle, Dafna Abelson, Ana I. Kuehne, Albert Wang, Russell R. Bakken, Akaash K. Mishra, Marissa Middlecamp, Elizabeth Champney, Lauran Stuart, Daniel P. Maurer, Jiannan Li, Jacob Berrigan, Jennifer Barajas, Stephen Balinandi, Julius J. Lutwama, Leslie Lobel, Larry Zeitlin, Laura M. Walker, John M. Dye, Kartik Chandran, Andrew S. Herbert, Noel T. Pauli, Jason S. McLellan

    Published 2024-07-01
    Get full text
    Article

Search Tools: